Ron Johnson actually said...

I want to get to the real crux of the problem here, because I think we are confusing the approval rate versus the ability of a patient like ...

The cost. Companies develop drugs because, in the end, they are reporting to shareholders and they have to make a profit.

There is just something, in terms of the FDA making these decisions for parents and patients, that we have to come to grips with.

There has to be some way to give those parents the right to just, actually, make sure they get the drug.